Ultragenyx Pharmaceutical Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
53,377.00
187,487.00
437,147.00
381,559.00
234,954.00
459,977
Total Accounts Receivable
-
-
-
-
5,172.00
12,740
Inventories
-
-
-
-
757.00
7,065
Other Current Assets
1,848.00
5,929.00
13,060.00
20,136.00
28,700.00
42,587
Total Current Assets
55,225.00
193,416.00
450,207.00
401,695.00
269,583.00
522,369
Net Property, Plant & Equipment
1,325.00
3,033.00
7,373.00
17,055.00
21,837.00
20,046
Total Investments and Advances
451.00
744.00
101,394.00
120,039.00
12,067.00
1,822
Intangible Assets
-
-
-
-
185,951.00
173,629
Other Assets
2,648.00
774.00
595.00
1,837.00
1,315.00
1,692
Total Assets
59,649.00
197,967.00
559,569.00
540,626.00
490,753.00
719,558
Accounts Payable
1,437.00
-
-
5,364.00
8,886.00
Other Current Liabilities
4,484.00
12,517.00
27,918.00
54,895.00
62,128.00
Total Current Liabilities
5,921.00
12,517.00
27,918.00
60,259.00
71,014.00
Deferred Taxes
-
-
-
-
31,166.00
Other Liabilities
3,619.00
505.00
561.00
6,393.00
5,119.00
Total Liabilities
9,540.00
13,022.00
28,479.00
66,652.00
107,299.00
Common Equity (Total)
74,821.00
184,945.00
531,090.00
473,974.00
383,454.00
Total Shareholders' Equity
50,109.00
184,945.00
531,090.00
473,974.00
383,454.00
Total Equity
50,109.00
184,945.00
531,090.00
473,974.00
383,454.00
Liabilities & Shareholders' Equity
59,649.00
197,967.00
559,569.00
540,626.00
490,753.00
Preferred Stock (Carrying Value)
124,930.00
-
-
-
-
About Ultragenyx Pharmaceutical
View Profile
